REG - MyHealthChecked PLC - Cond Subscription-Update re HMRC Advance Assurance

MyhealthcheckedAnnouncement

17/02/2021 07:02

RNS Number : 3090P
  
MyHealthChecked PLC
  
17 February 2021
  
 

 
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED.  ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
 
MyHealthChecked plc
("MyHealthChecked" or "the Company")
 
Conditional Subscription - Update re HMRC Advance Assurance
 
Further to the announcements of 29 January 2021, MyHealthChecked plc (AIM: MHC), the consumer home-testing healthcare company, announces it has now received Advance Assurance from HM Revenue and Customs that the ordinary shares to be issued are eligible for relief under the Enterprise Investment Scheme. This fulfils one of the conditions for the allotment of the 28,571,428 Conditional Subscription Shares detailed in the 29 January 2021 announcements. 
 
The allotment of the Conditional Subscription Shares remains conditional, inter alia, upon approval by Shareholders of the Resolutions to be proposed at the General Meeting scheduled for 11.00 a.m. on 18 February 2021.
 
Application will be made for admission of the Conditional Subscription Shares to trading on AIM; it is expected that the Conditional Subscription Shares will be admitted to trading on AIM ("Admission") at 8.00 a.m. on or around 22 February 2021.
 
Total Voting Rights
Following Admission, the Company will have a total of 725,246,036 Ordinary Shares in issue with each Ordinary Share carrying the right of one vote. The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Capitalised terms not otherwise defined in this announcement shall have the same meaning ascribed to such terms in the announcement released on 29 January 2021 unless the context requires otherwise.
 
For further information please contact:
 
 




MyHealthChecked plc


www.myhealthcheckedplc.com




Penny McCormick, Chief Executive Officer


via Walbrook PR




Maddy Kennedy, Chief Financial Officer


 




 


 




SPARK Advisory Partners Limited (NOMAD)


Tel: +44 (0)20 3368 3550




Neil Baldwin 


 




 


 




Oberon Investments  (Broker)


Tel: +44 (0)203 179 5344




Mike Seabrook


mikeseabrook@oberoninvestments.com




 


 




Walbrook PR Ltd (Media & Investor Relations)


Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com




Paul McManus


Mob: +44(0)7980 541 893 




 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCEAXAKFSXFEFA